EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Salivary Biomarkers for Alzheimer’s Disease: A Systematic Review with Meta-Analysis

Kacper Nijakowski iD, Wojciech Owecki, Jakub Jankowski iD, Anna Surdacka iD

International Journal of Molecular Sciences · 18.01.2024 · 25 (2) · 1168

DOI: 10.3390/ijms25021168 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.01.2024. Verfasst von Kacper Nijakowski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Conservative Dentistry and Endodontics, Poznan University of Medical Sciences, 60-812 Poznan, Poland. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases, MicroRNAs. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s Disease (AD) is the most common neurodegenerative disease which manifests with progressive cognitive impairment, leading to dementia. Considering the noninvasive collection of saliva, we designed the systematic review to answer the question “Are salivary biomarkers reliable for the diagnosis of Alzheimer’s Disease?” Following the inclusion and exclusion criteria, 30 studies were included in this systematic review (according to the PRISMA statement guidelines). Potential biomarkers include mainly proteins, metabolites and even miRNAs. Based on meta-analysis, in AD patients, salivary levels of beta-amyloid42 and p-tau levels were significantly increased, and t-tau and lactoferrin were decreased at borderline statistical significance. However, according to pooled AUC, lactoferrin and beta-amyloid42 showed a significant predictive value for salivary-based AD diagnosis. In conclusion, potential markers such as beta-amyloid42, tau and lactoferrin can be detected in the saliva of AD patients, which could reliably support the early diagnosis of this neurodegenerative disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeurodegenerative DiseasesMicroRNAsHumansLactoferrinBiomarkers

Stichwörter der Autor:innen

Alzheimer’s Diseasebeta-amyloidbiomarkerslactoferrinneurodegenerative diseasessalivatau

Substanzen

LactoferrinMicroRNAsBiomarkers

Autor:innen und Institutionen

  • Department of Conservative Dentistry and Endodontics, Poznan University of Medical Sciences, 60-812 Poznan, Poland.
  • Student's Scientific Group in Department of Conservative Dentistry and Endodontics, Poznan University of Medical Sciences, 60-812 Poznan, Poland.

ORCID-Profile: Kacper Nijakowski, Jakub Jankowski, Anna Surdacka

Zitieren

APA

Nijakowski, K., Owecki, W., Jankowski, J., & Surdacka, A. (2024). Salivary Biomarkers for Alzheimer’s Disease: A Systematic Review with Meta-Analysis. International Journal of Molecular Sciences, 25(2), 1168. https://doi.org/10.3390/ijms25021168

Vancouver

Nijakowski K, Owecki W, Jankowski J, Surdacka A. Salivary Biomarkers for Alzheimer’s Disease: A Systematic Review with Meta-Analysis. International Journal of Molecular Sciences. 2024;25(2):1168. doi:10.3390/ijms25021168

BibTeX
@article{Nijakowski2024,
  author = {Nijakowski, Kacper and Owecki, Wojciech and Jankowski, Jakub and Surdacka, Anna},
  title = {Salivary Biomarkers for Alzheimer’s Disease: A Systematic Review with Meta-Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {2},
  pages = {1168},
  doi = {10.3390/ijms25021168}
}
Kostenlos starten →